1. Determinants of Treatment Response in Painful Diabetic Peripheral Neuropathy: A Combined Deep Sensory Phenotyping and Multimodal Brain MRI Study
- Author
-
Mohammad Awadh, Iain D. Wilkinson, Francesa Heiberg-Gibbons, Pallai Shillo, Kevin Teh, Gordon Sloan, Dinesh Selvarajah, Alan Kelsall, and Solomon Tesfaye
- Subjects
Adult ,Male ,0301 basic medicine ,Adolescent ,Endocrinology, Diabetes and Metabolism ,030209 endocrinology & metabolism ,Sensory system ,Somatosensory system ,law.invention ,Cohort Studies ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Diabetic Neuropathies ,Randomized controlled trial ,law ,Surveys and Questionnaires ,Internal Medicine ,Humans ,Medicine ,Young adult ,Aged ,business.industry ,Brain ,Lidocaine ,Odds ratio ,Middle Aged ,medicine.disease ,Magnetic Resonance Imaging ,Observational Studies as Topic ,Phenotype ,030104 developmental biology ,Peripheral neuropathy ,Anesthesia ,Nociceptor ,Female ,business ,Cohort study - Abstract
Painful diabetic peripheral neuropathy (DPN) is difficult to manage, as treatment response is often varied. The primary aim of this study was to examine differences in pain phenotypes between responders and nonresponders to intravenous lidocaine treatment using quantitative sensory testing. The secondary aim was to explore differences in brain structure and functional connectivity with treatment response. Forty-five consecutive patients who received intravenous lidocaine treatment for painful DPN were screened. Twenty-nine patients who met the eligibility criteria (responders, n = 14, and nonresponders, n = 15) and 26 healthy control subjects underwent detailed sensory profiling. Subjects also underwent multimodal brain MRI. A greater proportion of patients with the irritable (IR) nociceptor phenotype were responders to intravenous lidocaine treatment compared with nonresponders. The odds ratio of responding to intravenous lidocaine was 8.67 times greater (95% CI 1.4–53.8) for the IR nociceptor phenotype. Responders to intravenous lidocaine also had significantly greater mean primary somatosensory cortex cortical volume and functional connectivity between the insula cortex and the corticolimbic circuitry. This study provides preliminary evidence for a mechanism-based approach for individualizing therapy in patients with painful DPN.
- Published
- 2020
- Full Text
- View/download PDF